• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AAO’s IRIS Registry recognized by CMS

Article

The American Academy of Ophthalmology’s Intelligent Research in Sight (IRIS) Registry has been recognized by the Centers for Medicare and Medicaid Services (CMS) as an approved vehicle for enhanced federal quality reporting.

 

San Francisco-The American Academy of Ophthalmology’s Intelligent Research in Sight (IRIS) Registry has been recognized by the Centers for Medicare and Medicaid Services (CMS) as an approved vehicle for enhanced federal quality reporting.

The ophthalmic database received two important Physician Quality Reporting System designations-a qualified registry and qualified clinical data registry. These two approvals represent key milestones in the academy’s ongoing efforts to use information technology to improve and innovate patient care.

“Securing these designations is a significant milestone for the medical specialty of ophthalmology,” said William L. Rich III, MD, medical director of health policy for the academy. “Through the IRIS Registry, ophthalmology now has the power to design specialty-specific measures that will enhance the value of CMS quality reporting and help improve patient outcomes.”

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.